Sugar Editorial Picks
Aug 23, 2007 -
Looking for another reason to have that glass of wine tonight?
Well, during the months of September and October Fat Bastard (sells for $10.99) will donate 25 cents for every bottle sold to support breast cancer research, education, screening and patient support. So why not have a glass of wine, not only will you be supporting the fight against breast cancer, but one or two glasses are supposed to be beneficial to your health.
- 12 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
Screening
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Lifestyle Changes
- Diagnostic Tests
- Staging Systems
- Surgical Procedures
- Radiation Treatments
- Treatment Options by Stages...
- Chemotherapy Treatments
- Investigative Agents
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Research News:
- About 3,000 nonsmokers die each year of lung cancer resulting from exposure to secondhand smoke, according to a 2006 Surgeon General report.
- Advexin, a genetic therapy that contains the p53 tumor-suppressor gene, is showing promise. A 2006 study in Japan found that out of 13 patients with advanced NSCLC receiving Advexin, 10 had stabilized. Advexin is in Phase II clinical trials for NSCLC.
- Studies are finding that NSCLC tumors in people who never smoked have a much higher rate of epithelial growth-factor receptor (EGFR) mutations.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Complications
- Symptoms
- Lifestyle Changes
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Black Cohosh Doesn’t Help Hot Flashes
- The herbal remedy black cohosh is no better than placebo for treating hot flashes and night sweats, according to a 2006 study in the Annals of Internal Medicine.
- Most complementary and alternative medicines are ineffective for relieving menopausal symptoms, according to a 2006 review in the Archives of Internal Medicine.
Hormone Replacement Therapy (HRT)
- Short-term use of HRT remains an option for recently menopausal women who have a low risk for stroke, according to a 2007 statement from the North American Menopause Society (NAMS). However, NAMS recommends that women who are at risk for heart disease or breast cancer should consider other approaches for managing hot flashes.
- For women who want to discontinue HRT, gradually tapering off the medication or stopping it abruptly appears to make little difference in the recurrence of symptoms, suggests a 2006 study. A gradual approach may delay the reappearance of symptoms, but does not prevent them from returning.
HRT and Heart Disease: Timing Counts
Women who begin HRT within 10 years of menopause have a much lower risk for heart disease and heart attack than women who start HRT later on, indicates a 2007 study in the Journal of the American Medical Association.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- What Causes It?
- Who's Most At Risk?
- What to Expect at Your Provider's Office
- Treatment Options
- Prognosis/Possible Complications
- Following Up
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Skin cancer is generally a result of too much exposure to the sun. While skin cancer is the most common form of cancer, many types are both preventable and treatable. Skin cancer is classified into five different types:
- Basal cell carcinoma (BCC) is the most common form and accounts for 90% of all skin cancers.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Symptoms
- Diagnosis
- Outlook
- Staging and Treatment Guide...
- Chemotherapy
- Biologic Therapy (Immunothe...
- Radiation
- Transplantation
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
Chemotherapy can cause anemia, a drop in red blood cell (hemoglobin) levels. Erythropoiesis-stimulating drugs, which boost the production of red blood cells, are administered to counteract this complication. However, these drugs, which include epoietin alfa (Epogen, Procrit) and darbepoietin alfa (Aranesp), can also cause serious side effects and adversely affect survival when hemoglobin levels are raised too high.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Types of Psoriasis
- Causes
- Risk Factors
- Diagnosis
- Treatment
- Topical Medications
- Systemic Medications
- Phototherapy
- Managing Psoriasis
- Outlook
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Treatment
Psoriasis that develops on the hands or feet is often very difficult to treat. However, an advanced clinical trial showed that a medication called efalizumab (Raptiva) effectively cleared or nearly cleared moderate-to-severe symptoms in adults after 12 weeks.
Several studies have shown that most people with severe psoriasis who are treated with infliximab (Remicade) have significant improvement in symptoms by week 10.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Recommended Exercise Method...
- Exercise's Effects on the H...
- Exercise's Effects on Diabe...
- Exercise's Effects on Bones...
- Exercise's Effects on the L...
- Exercise's Effects on Weigh...
- Exercise's Effects on Other...
- Complications
- Motivation
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Chronic Conditions and Exercise:
- A new study found that aerobic and resistance training significantly reduced fatigue in men undergoing radiation treatments for prostate cancer. Fatigue is a common side effect of such treatments.
- Doctors at the Mayo Clinic found that exercise improves the physical and emotional well-being of patients with Alzheimer's disease. The patients exercised for as little as 60 minutes each week.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Dietary Changes
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
General Dietary Guidelines
- In 2006, the American Heart Association (AHA) revised its dietary and lifestyle recommendations. The new guidelines specifically recommend limiting daily saturated fat intake to less than 7% and trans fats to less than 1% of total daily calories.
- The AHA recommends consuming plenty of deep-colored vegetables and fruits, eating oily fish at least twice a week, and including whole grains in your daily diet.
Fish
- Women with existing heart disease may consider taking fish oil supplements, suggests 2007 AHA guidelines. Women should include a variety of low-mercury fish in their diet.
- 3 Comments